Kymera Therapeutics, Inc. (KYMR) NASDAQ
85.40
+0.47(+0.55%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
85.40
+0.47(+0.55%)
Currency In USD
| Market Cap | 6.57B |
| Enterprise Value | 6.29B |
| P/E Ratio | -23.14 |
| PEG Ratio | 8.31 |
| Price/Sales Ratio | 177.86 |
| Price/Book Ratio | 4.56 |
| Enterprise/Revenue | 170.85 |
| Enterprise/EBITDA | -22.15 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -7.94 |
| Operating Margin | -8.91 |
| Return On Assets | -0.18 |
| Return On Equity | -0.29 |
| Revenue | 39.2M |
| Revenue/Share | 0.46 |
| Gross Profit | 39.2M |
| EBITDA | -303.06M |
| Net Income | -311.4M |
| Diluted EPS | -3.69 |
| Total Cash | 848.28M |
| Total Cash/Share | 10.05 |
| Total Debt | 82.25M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 10.47 |
| Book Value Per Share | 18.72 |
| 52-Week Change | 286.95 |
| 52-Week High | 103 |
| 52-Week Low | 19.45 |
| Moving Average 50 Days | 81.07 |
| Moving Average 200 Days | 63.1 |
| Average Volume | 765,640 |
| Shares Outstanding | 81.64M |
| % Held by Institutions | 102.94 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |